Key result
Cyanotic CHD with polycythemia is linked to increased platelet microparticles, correlating with hematocrit above 60%.
Why the study?
The production of platelet microparticles and their role in coagulation abnormalities in patients with cyanotic congenital heart disease with polycythemia had not been elucidated.
Do patients with cyanotic congenital heart disease and polycythemia have altered platelet microparticle production and aggregation compared to patients with acyanotic congenital heart disease?
Observational (n=40)
Do patients with cyanotic congenital heart disease and polycythemia have altered platelet microparticle production and aggregation compared to patients with acyanotic congenital heart disease?
Answers are grounded in this paper and cite their sources.
Platelet microparticles are overproduced in patients with cyanotic congenital heart disease and polycythemia, potentially driven by blood hyperviscosity and contributing to coagulation abnormalities.
OBJECTIVES: We sought to clarify the role of platelets in the pathogenesis of abnormal coagulation in patients with cyanotic congenital heart disease (CCHD) with polycythemia; we evaluated the production of platelet microparticles (MPs), platelet degranulation and aggregation response, as well as the correlations of these variables with polycythemia. BACKGROUND: A shortened life span and suppressed aggregability of platelets are well known in patients with CCHD. Although platelet MPs are overproduced and play an important role in the coagulation process in various hematologic and cardiovascular disorders, the production of MPs remains to be elucidated in CCHD. We studied 19 patients who had CCHD with polycythemia and 21 age-matched subjects with acyanotic congenital heart disease (ACHD). Flow cytometry, using monoclonal antibodies, showed the presence of MPs as particles positive for the surface antigen (glycoprotein IIb/IIIa) specific to platelets, and platelet alpha-degranulation was recognized as platelets positive for the surface antigen of P-selectin. Platelet aggregation was assessed as the response to adenosine diphosphate (ADP). Relationships between these indexes and hematocrit (Hct) values were also evaluated. RESULTS: Production of MPs correlated positively with Hct and markedly increased at Hct values above 60% in patients with CCHD. Surface P-selectin and the mean platelet volume in patients with CCHD were comparable with those in patients with ACHD. The platelet aggregation response to ADP significantly and negatively correlated with Hct. In two subjects who showed hemoptysis and underwent phlebotomy, MPs were reduced 6 h after the procedure. CONCLUSIONS: Platelet MPs are overproduced in patients who have CCHD with polycythemia, probably due to a high shear stress derived from blood hyperviscosity. Circulating incompetent platelets, which have already been activated, as well as MPs, might play an important role in the coagulation abnormalities identified in such patients.
No takes yet. Share an insight, caveat, or question.
Horigome et al. (2002) conducted an observational in Cyanotic congenital heart disease with polycythemia (n=40). Cyanotic congenital heart disease with polycythemia vs. Acyanotic congenital heart disease was evaluated on Production of platelet microparticles. Cyanotic congenital heart disease with polycythemia was associated with overproduction of platelet microparticles, which correlated positively with hematocrit levels above 60%.
Synapse has enriched 10 related papers. Consider them for comparative context: